ClinicalTrials.govpublic full text
An Open Positron Emission Tomography Study to Assess the Effects of Varying Mass of AZD4694 on Radioligand Binding Parameters in Healthy Volunteers and Patients With Alzheimer's Disease
maximum diagnostic mass of [18fluor]azd4694, radioligand, alzheimers disease, maximum diagnostic mass, beta amyloid, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 868727
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.